Human Health Holdings Limited (HKG:1419)
0.8300
0.00 (0.00%)
Jun 13, 2025, 9:55 AM HKT
Human Health Holdings Revenue
Human Health Holdings had revenue of 315.79M HKD in the half year ending December 31, 2024, a decrease of -53.65%. This brings the company's revenue in the last twelve months to 611.42M, down -0.69% year-over-year. In the fiscal year ending June 30, 2024, Human Health Holdings had annual revenue of 590.82M, down -41.02%.
Revenue (ttm)
611.42M
Revenue Growth
-0.69%
P/S Ratio
0.52
Revenue / Employee
1.06M
Employees
743
Market Cap
315.03M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Jun 30, 2024 | 590.82M | -410.93M | -41.02% |
Jun 30, 2023 | 1.00B | -120.05M | -10.70% |
Jun 30, 2022 | 1.12B | 467.08M | 71.34% |
Jun 30, 2021 | 654.71M | 200.98M | 44.29% |
Jun 30, 2020 | 453.74M | -74.85M | -14.16% |
Jun 30, 2019 | Pro | Pro | Pro |
Jun 30, 2018 | Pro | Pro | Pro |
Jun 30, 2017 | Pro | Pro | Pro |
Jun 30, 2016 | Pro | Pro | Pro |
Jun 30, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
BeOne Medicines | 32.53B |
Hansoh Pharmaceutical Group Company | 13.05B |
Innovent Biologics | 10.03B |
JD Health International | 61.89B |
WuXi Biologics | 19.87B |
CSPC Pharmaceutical Group | 28.99B |
Sino Biopharmaceutical | 30.72B |
Akeso | 2.26B |